This week’s newsletter covers new research on cannabis for treatment-resistant depression, CBD’s potential in cardiovascular health and traumatic brain injury recovery, the therapeutic promise of acidic cannabinoids like THCA and CBDA, and an unexpected interaction between CBD, THC, and caffeine.
Noteworthy Read
Study: Cannabis Treatment Provides Sustained Relief for Patients with Treatment-Resistant Depression (NORML)
A longitudinal study using data from the UK Medical Cannabis Registry found that patients with treatment-resistant depression who were prescribed cannabis-based medicinal products (including herbal cannabis and THC/CBD oil extracts) reported sustained and clinically meaningful improvements in depression, anxiety, sleep quality, and overall health-related quality of life over a 24-month period.
Read the articleView more in THC
More Noteworthy Reading
CBD in Cardiovascular Disease (Mayo Clinic Proceedings)
A review in Mayo Clinic Proceedings discusses evidence that cannabidiol (CBD) may benefit cardiovascular health by reducing inflammation, oxidative stress, endothelial dysfunction, and arrhythmias, though large clinical trials are needed to confirm therapeutic effects.
Read moreView more in CBD
CBD a Tool for Fetal Alcohol Syndrome (Medical Life Sciences)
Preclinical research suggests cannabidiol (CBD) could mitigate neurological damage associated with fetal alcohol spectrum disorders by reducing neuroinflammation and supporting synaptic function.
Read moreView more in CBD
Therapeutic Potential of Acidic Cannabinoids (Journal of Cannabis Research)
A review in the Journal of Cannabis Research highlights how acidic cannabinoids like THCA and CBDA have anti-inflammatory, anti-nausea, neuroprotective, and anti-tumor properties, suggesting potential medical applications distinct from their neutral counterparts.
Read moreView more in Endocannabinoid System
CBD Improves Cognitive Impairment After Traumatic Brain Injury (Phytomedicine)
A Phytomedicine study found that cannabidiol (CBD) improved cognitive deficits and reduced neuroinflammation in animal models of traumatic brain injury, indicating potential for post-injury therapeutic use.
Read moreView more in CBD
Research Round-Up
Unexpected Interaction Between CBD and THC in Caffeinated Beverages (PsyPost)
A PsyPost article reports that when CBD and THC are combined in caffeinated drinks, users experience altered subjective effects and pharmacokinetics, suggesting caffeine modulates how these cannabinoids are absorbed and felt.
Read moreView more in Drug Interactions
A heartfelt thank you to all of the CBD brands whose generous support makes it possible for Project CBD to bring you the latest in plant medicine research and journalism each week. We’re grateful for every one of you.
Be the first to comment